(Republished from www.sciencedaily.com)
A novel therapy tested by University of Guelph scientists for treating a fatal heart disorder in dogs might ultimately help in diagnosing and treating heart disease in humans.
Ontario Veterinary College (OVC) professors Glen Pyle and Lynne O'Sullivan have also identified potential causes of inherited dilated cardiomyopathy (DCM) or "weak heart."
The groundbreaking study was published this month in the American Journal of Physiology.
"The cardiovascular systems of dogs and people are very similar," said Pyle, a professor in OVC's Department of Biomedical Sciences and a member of U of G's Centre for Cardiovascular Investigations.
"It allows us do comparative investigations that can advance understanding of this fatal condition."
In both dogs and people with DCM, the weakened heart muscle becomes unable to pump blood around the body. The cause of the problem is often unknown, although it's common to involve genetics.
Researchers suspect malfunctioning muscle proteins cause the heart to weaken, allowing it to dilate like an overfilled balloon.
DCM is the second leading cause of heart failure in dogs, and it's especially common in large breeds. Dogs typically show no symptoms until the disease is well-advanced.
The condition is often inherited; up to 60 per cent of Doberman Pinschers are affected during their lifetime. Other breeds such as Irish wolfhounds and Great Danes also have high rates.
In people, 30 to 50 per cent of DCM cases are hereditary.
The end result of DCM is congestive heart failure. While medical advances have reduced deaths from congestive heart failure by 40 per cent in the past decade, the condition still afflicts hundreds of thousands of Canadians, and the five-year mortality rate remains high.
Aging populations worldwide are likely to cause dramatic increases in the rate of heart failure in the upcoming decades, Pyle said.
"The cause of a substantial percentage of DCM cases remains unknown," he said. "This is why it's urgent to develop novel agents that can improve heart function."
For the study, Pyle and O'Sullivan, a clinical cardiologist in OVC's Health Sciences Centre, worked with researchers at the University of Washington to test a novel therapy in diseased heart cells.
The therapy involves introducing a molecule involved in muscle contraction. In heart cells from dogs with DCM, it restored normal function. The next step is developing a gene therapy that would allow the molecule to be produced in heart muscle cells in patients with DCM.
"This suggests it's a promising therapeutic approach worth further investigating for the treatment of DCM," said O'Sullivan. One of 10 board-certified veterinary cardiologists in Canada, she runs OVC's Doberman DCM screening program.
The researchers also discovered some problems in the heart muscle that likely contribute to DCM. "This may shed light on the mechanical impairment in failing hearts," Pyle said.
The Guelph scientists are also working with researchers in Finland on DCM genetics and proteins. That work might lead to development of therapies for targeting specific proteins, said Pyle.
Both researchers belong to U of G's Centre for Cardiovascular Investigations, one of a few centres worldwide studying heart disease from single molecules to clinical applications.
The GMDF Club Doberman Specialty at the International Centre was very well attended. Here is a small slice of highlights. For results please visit this link.
Do you have photos & brags that you would like listed?
Club Members please email them to email@example.com
On the weekend of September 19th and 20th, The Greater Mid-Ontario Doberman Fanciers manned a booth at the Pet Expo at the International Centre in Mississauga. The event was well attended by the general public and the doberman booth was a busy place, fielding questions about the breed, temperament, training, ear cropping and where to get a puppy. Of course we were debunking the myths too!
Members brought dogs, who were great ambassadors for breed, greeting all visitors with wagging tails, a head ready to be petted and in the case of the 5 month old pup lots of kisses.
Special thanks to:
Submitted by: Elizabeth Numbers, President of GMDF
WHAT IS A TITLE?
It is not just a brag, not just a stepping stone to a higher title, not just an adjunct to competitive scores.
A title is a tribute to the dog that bears it, a way to honour the dog, an ultimate memorial.
It will remain in the record and in the memory for about as long as anything in this world can remain. And although the dog itself does not know or care that its achievements are noted, a title says many things in the world of humans where such things count.
A title says your dog was intelligent, adaptable and good-natured. It says your dog loved you enough to do the things that pleased you, however crazy they may have seemed. In addition, a title says that you loved your dog, that you loved to spend time with your dog because it was a good dog, and that you believed in your dog enough to give it yet another chance when it failed, and in the end, your faith was justified.
A title proves that your dog inspired you to that special relationship enjoyed by so few, that in a world of disposable creatures, this dog with a title was greatly loved and loved greatly in return.
And when that dear short life is over, the title remains as a memorial of the finest kind, the best you can give to a deserving friend, volumes of praise in one small set of initials before or after the name. A title is nothing less than true love and respect, given and permanently recorded.
(I found this document in the bottom of my “dog drawer” when I was cleaning it out. I’m sure it has been around the block many times, but for those of you who haven’t seen it, enjoy!)-Ace